Thoratec kept at sector perform by RBC

RBC Capital Markets analyst Phil Nalbone maintained Thoratec Corp. at its sector perform rating, speculative risk, after the company reported second-quarter revenue up 15% at $54.8 million, beating the analyst's estimate of $51.9 million and the consensus Street estimate of $50.9 million. Second-quarter GAAP earnings per share of $0.01 fell short of RBC's estimate of $0.02 and is down from the $0.05 reported in the same period last year. Non-GAAP earnings per share was in line with the analyst's estimate of $0.09 and beat the consensus Street estimate by 1 cent. Shares of the Pleasanton, Calif.-based medical device manufacturing company were up 35 cents, or 2.54%, at $14.15, on volume of 1,679,583 shares versus the three-month running average of 679,583 shares. (Nasdaq: THOR)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.